| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |